Literature DB >> 12046074

The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.

Hu Liu1, Yuan Wang, Qing Zhou, Shu-Yu Gui, Xu Li.   

Abstract

AIM: In hepatocellular carcinoma (HCC) prevalent areas of China, the point mutation of p53 exon7 is highly correlated with Hepatitis B virus(HBV) infection and aflatoxin B intake. While in non-HCC-prevalent areas of China, these factors are not so important in the etiology of HCC. Therefore, the point mutation of p53 exon7 may also be different than that in HCC-prevalent areas of China. The aim of this study is to investigate the status and carcinogenic role of the point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non-HCC-prevalent area in China.
METHODS: PCR PCR-SSCP and PCR-RFLP were applied to analyze the homozygous deletion and point mutation of p53 exon7 in HCC samples from Anhui, which were confirmed by DNA sequencing and Genbank comparison.
RESULTS: In the 38 samples of hepatocellular carcinoma, no homozygous deletion of p53 exon7 was detected and point mutations of p53 exon7 were found in 4 cases, which were found to be heterozygous mutation of codon 249 with a mutation rate of 10.53%(4/38). The third base mutation(G-T) of p53 codon 249 was found by DNA sequencing and Genbank comparison.
CONCLUSION: The incidence of point mutation of p53 codon 249 is lower in hepatocellular carcinoma and the heterozygous mutation of p53 exon7 found in these patients only indicate that they have genetic susceptibility to HCC. p53 codon 249 is a hotspot of p53 exon7 point mutation, suggesting that the point mutation of p53 exon 7 may not play a major role in the carcinogenesis of HCC in Anhui Province, a non-HCC-prevalent area in China.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046074      PMCID: PMC4656425          DOI: 10.3748/wjg.v8.i3.480

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Authors:  B Bressac; K M Galvin; T J Liang; K J Isselbacher; J R Wands; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions.

Authors:  C C Lee; J Y Liu; J K Lin; J S Chu; J Y Shew
Journal:  Cancer Lett       Date:  1998-03-13       Impact factor: 8.679

3.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

4.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

Authors:  S P Hussain; K Raja; P A Amstad; M Sawyer; L J Trudel; G N Wogan; L J Hofseth; P G Shields; T R Billiar; C Trautwein; T Hohler; P R Galle; D H Phillips; R Markin; A J Marrogi; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  Concomitant inactivation of p53 and Chk2 in breast cancer.

Authors:  Alexandra Sullivan; Martin Yuille; Claire Repellin; Archana Reddy; Olivier Reelfs; Alexandra Bell; Barbara Dunne; Barry A Gusterson; Peter Osin; Paul J Farrell; Isik Yulug; Abigail Evans; Tayfun Ozcelik; Milena Gasco; Tim Crook
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

7.  Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions.

Authors:  Z Zhang; Y Yuan; H Gao; M Dong; L Wang; Y H Gong
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

8.  Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2.

Authors:  Suzanne M Johnson; Jacqueline A Shaw; Rosemary A Walker
Journal:  Int J Cancer       Date:  2002-03-10       Impact factor: 7.396

9.  p53 and microvessel density in primary resection specimens of superficial bladder cancer.

Authors:  Frank Reiher; Ozden Ozer; Michael Pins; Borko D Jovanovic; Scott Eggener; Steven C Campbell
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

10.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

View more
  11 in total

1.  Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.

Authors:  Xin-Juan Kong; Yu-Hu Song; Ju-Sheng Lin; Huan-Jun Huang; Nan-Xia Wang; Nan-Zhi Liu; Bin Li; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.

Authors:  Peng Liao; Shelya X Zeng; Xiang Zhou; Tianjian Chen; Fen Zhou; Bo Cao; Ji Hoon Jung; Giannino Del Sal; Shiwen Luo; Hua Lu
Journal:  Mol Cell       Date:  2017-12-07       Impact factor: 17.970

4.  DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Authors:  Zhao-Chong Zeng; Guo-Liang Jiang; Guo-Min Wang; Zhao-You Tang; Walter J Curran; George Iliakis
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.

Authors:  Shao-Shan Wang; Ti Zhang; Xi-Lu Wang; Li Hong; Qing-Hui Qi
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

6.  Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application.

Authors:  Li-Wu Lin; Xue-Ying Lin; Yi-Mi He; Shang-Da Gao; Xiao-Dong Lin
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

7.  Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.

Authors:  Xiao-Yong Fu; Hong-Yang Wang; Lu Tan; Shu-Qin Liu; Hui-Fang Cao; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

8.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Expression of hepatitis B virus X protein in transgenic mice.

Authors:  Jun Xiong; Yu-Cheng Yao; Xiao-Yuan Zi; Jian-Xiu Li; Xin-Min Wang; Xu-Ting Ye; Shu-Min Zhao; Yong-Bi Yan; Hong-Yu Yu; Yi-Ping Hu
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

Review 10.  A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer.

Authors:  Hajar Ku Yasin; Anthony H Taylor; Thangesweran Ayakannu
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.